Roche Diagnostics GmbH (manufacturing of unpackaged products, primary packaging, quality control testing)

Ukraine

All drugs from this manufacturer

  • PERYETA

    The drug is used to treat various forms of breast cancer, specifically early-stage cancer (both pre- and post-surgery) and metastatic or locally recurrent cancer that is HER2-positive.

    Dosage form: concentrate for infusion solution

    Active substance Dosage
    pertuzumab 30 mg/ml

    ATC: L01FD02

  • TECENTRIQ

    The drug is prescribed for the treatment of various types of cancer, including non-small cell lung cancer (adjuvant treatment or treatment of metastatic cancer), small cell lung cancer, as well as hepatocellular carcinoma (liver cancer).

    Dosage form: concentrate for infusion solution

    Active substance Dosage
    atezolizumab 1200 mg/20 ml

    ATC: L01FF05